Search Our Site

Cancer drug spending doubled in last 5 years, report says

Cancer drug spending doubled in last 5 years, report says

Blood samples taken from a patient receiving CAR-T cell therapy at the Fred Hutchinson Cancer Research Center in Seattle.Elaine Thompson / AP Spending on cancer drugs has doubled over the past five years, and little wonder: Every new cancer drug brought to market last year cost $100,000 or more, according to a new report. The... Read More »

Read More →

Blood samples taken from a patient receiving CAR-T cell therapy at the Fred Hutchinson Cancer Research Center in Seattle.Elaine Thompson / AP Spending on cancer drugs has doubled over the past five years, and little wonder: Every new cancer drug brought to market last year cost $100,000 or more, according to a new report. The… Read More »

[...]

Read More

Insys Update: Stunning Numbers, Devastating Results

By: Jason Marcewicz  |  Content and Communications Specialist | Advanced Medical Strategies The pharmaceutical company Insys Therapeutics has been in the news a lot recently—and for all the wrong reasons. Last September AMS reported about Insys’ schemes to sell more of their pain drug Subsys to unwitting physicians. Now, it seems that Insys didn’t just... Read More »

Read More →

By: Jason Marcewicz  |  Content and Communications Specialist | Advanced Medical Strategies The pharmaceutical company Insys Therapeutics has been in the news a lot recently—and for all the wrong reasons. Last September AMS reported about Insys’ schemes to sell more of their pain drug Subsys to unwitting physicians. Now, it seems that Insys didn’t just… Read More »

[...]

Read More

This ‘metastasis-blocking’ compound may stop the spread of cancer

Using a new approach, scientists have located a compound that stops the spread of breast, pancreatic, and prostate cancers in mice. The compound — which they call metarrestin — destroys a unique structure inside the nucleus of cancer cells that can spread and form new tumors. A paper on the work — in which researchers... Read More »

Read More →

Using a new approach, scientists have located a compound that stops the spread of breast, pancreatic, and prostate cancers in mice. The compound — which they call metarrestin — destroys a unique structure inside the nucleus of cancer cells that can spread and form new tumors. A paper on the work — in which researchers… Read More »

[...]

Read More

Oncimmune Holdings plc Launches EarlyCDT®-Liver Test in the US

Oncimmune Holdings plc (LON:ONC), a leading early cancer detection company developing and commercialising its proprietary EarlyCDT® liquid biopsy platform technology, today announced that it has completed development of its EarlyCDT®-Liver test for hepatocellular carcinoma (HCC), and that it will be commercially available from today in the US. The test has high specificity at 97% and... Read More »

Read More →

Oncimmune Holdings plc (LON:ONC), a leading early cancer detection company developing and commercialising its proprietary EarlyCDT® liquid biopsy platform technology, today announced that it has completed development of its EarlyCDT®-Liver test for hepatocellular carcinoma (HCC), and that it will be commercially available from today in the US. The test has high specificity at 97% and… Read More »

[...]

Read More

CAR T Therapy Case Study Shows Early Success in Treatment of Acute Myeloid Leukemia

There are currently 2 FDA-approved chimeric antigen receptor (CAR) T-cell therapies available in the United States, tisagenlecleucel (Kymriah) and axicabtagene ciloleucel (Yescarta). Both therapies are indicated to treat adult patients with relapsed or refractory diffuse large B-cell lymphoma; however, Kymriah holds an additional indication to treat B-cell precursor acute lymphoblastic leukemia in certain pediatric and... Read More »

Read More →

There are currently 2 FDA-approved chimeric antigen receptor (CAR) T-cell therapies available in the United States, tisagenlecleucel (Kymriah) and axicabtagene ciloleucel (Yescarta). Both therapies are indicated to treat adult patients with relapsed or refractory diffuse large B-cell lymphoma; however, Kymriah holds an additional indication to treat B-cell precursor acute lymphoblastic leukemia in certain pediatric and… Read More »

[...]

Read More

Penn Docs Have Performed the World’s First Robot-Assisted Spinal Surgery

Surgeons at Penn have officially made history after successfully completing the world’s first robotically assisted spinal surgery, the institution has announced. Doctors completed the procedure last August over two days and more than 20 hours. Now nine months later, the patient is back to his normal life. Noah Pernikoff, a 27-year-old commercial contractor living in... Read More »

Read More →

Surgeons at Penn have officially made history after successfully completing the world’s first robotically assisted spinal surgery, the institution has announced. Doctors completed the procedure last August over two days and more than 20 hours. Now nine months later, the patient is back to his normal life. Noah Pernikoff, a 27-year-old commercial contractor living in… Read More »

[...]

Read More

Researchers develop computer-designed, customised regenerative heart valves

Producing living tissue or organs based on human cells is one of the main research fields in regenerative medicine. Tissue engineering, which involves growing replacement parts in the laboratory, forms a key part of this research. The parts can be used to replace defective cells and tissues in the body and restore their normal functioning.... Read More »

Read More →

Producing living tissue or organs based on human cells is one of the main research fields in regenerative medicine. Tissue engineering, which involves growing replacement parts in the laboratory, forms a key part of this research. The parts can be used to replace defective cells and tissues in the body and restore their normal functioning…. Read More »

[...]

Read More

NPR Podcast: The Only Prescription Is More Transparency

Listen to NPR’s “The Indicator” podcast here! Healthcare is a giant part of the economy, and a huge drain on the public purse. More than a quarter of federal government spending goes to healthcare, which makes it a very political issue. President Trump has stated his intention to create a more consumer friendly healthcare system…... Read More »

Read More →

Listen to NPR’s “The Indicator” podcast here! Healthcare is a giant part of the economy, and a huge drain on the public purse. More than a quarter of federal government spending goes to healthcare, which makes it a very political issue. President Trump has stated his intention to create a more consumer friendly healthcare system…… Read More »

[...]

Read More

AHA, AARP blast big pharma for not doing enough to curb drug price increases

American Hospital Association President and CEO Rick Pollack, along with the CEO of the American Association of Retired Persons Jo Ann Jenkins, called out the pharmaceutical industry for not doing its part to cut healthcare costs. Pollack and Jenkins cited recent research showing that drug prices have continued to spike in recent years at alarming... Read More »

Read More →

American Hospital Association President and CEO Rick Pollack, along with the CEO of the American Association of Retired Persons Jo Ann Jenkins, called out the pharmaceutical industry for not doing its part to cut healthcare costs. Pollack and Jenkins cited recent research showing that drug prices have continued to spike in recent years at alarming… Read More »

[...]

Read More

By: Jason Marcewicz  |  Content and Communications Specialist | Advanced Medical Strategies Spinal cord stimulation (SCS) is a pain-relief technique that continuously delivers a low-voltage electrical current to the spinal cord to block the sensation of pain. SCS is the most commonly used implantable neurostimulation technology for management of pain syndromes. As many as 50,000… Read More »

[...]

Read More

Page 1 of 43

Categories
Archives